Extended Data Fig. 10: Gating strategy for identifying lymph node dendritic cells containing nanoparticle and tumour antigen.
From: STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

The gating strategy used to identify tumour dendritic cells [CD45+ DUMP(Ly6G CD19 CD3e NK1.1)- CD11c+] containing tumour antigen (ZsGreen) or nanoparticle (Cy5 detected in the APC channel) is shown (see methods for details on tumour digestion and the antibodies used for staining).